论文信息 - Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. - 字舞流文

Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

W. Scheithauer | E. Van Cutsem | M. Moore | W. Vervenne | C. Verslype | Y. Humblet | S. Gill | J. Van Laethem | J. Bennouna | J. Cosaert | A. Shang